0001093557-20-000247.txt : 20200911
0001093557-20-000247.hdr.sgml : 20200911
20200911185732
ACCESSION NUMBER: 0001093557-20-000247
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200909
FILED AS OF DATE: 20200911
DATE AS OF CHANGE: 20200911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abbey Donald
CENTRAL INDEX KEY: 0001534342
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 201171940
MAIL ADDRESS:
STREET 1: 3750 TORREY VIEW COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-09-09
0
0001093557
DEXCOM INC
DXCM
0001534342
Abbey Donald
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
EVP Quality and Regulatory Aff
Common Stock
2020-09-09
4
S
0
5159
391.0
D
54782
D
Common Stock
2020-09-09
4
S
0
1283
398.302
D
53499
D
Common Stock
2020-09-09
4
S
0
3297
398.302
D
50202
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey.
Included in this number are 22,722 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
By: Jereme Sylvain For: Donald M Abbey
2020-09-11